🇪🇺 Sufentanil Bolus in European Union

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

EMA authorised Sufentanil Bolus on 25 June 2018

Marketing authorisation

EMA — authorised 25 June 2018

Application: EMEA/H/C/004335
Marketing authorisation holder: Laboratoire Aguettant
Local brand name: Dzuveo
Indication: Dzuveo is indicated for the management of acute moderate to severe pain in adult patients.
Status: approved

Read official source →

Frequently asked questions

Is Sufentanil Bolus approved in European Union?

Yes. EMA authorised it on 25 June 2018.

Who is the marketing authorisation holder for Sufentanil Bolus in European Union?

Laboratoire Aguettant holds the EU marketing authorisation.